Filter by: patients
Home > Community Treatment Reports and Side Effects > Tobramycin Treatment Report
What is Tobramycin?

Tobramycin is an antibiotic used for susceptible gram-negative bacilli; topically for susceptible eye infections; as an inhalant it is used for management of Pseudomonas aeruginosa in cystic fibrosis patients.

Reported Purpose & Efficacy

Reasons and Efficacy
Purpose # of patients
# of patients with evaluations Efficacy
Major
Moderate
Slight
None
Can’t tell
Cystic Fibrosis 15 1 Efficacy_cant_tell
Bronchiectasis 2 0
Pneumonia symptoms 1 0
Respiratory infections 1 0
Increased secretions 1 1 Efficacy_none
Doctor recommendation 1 0

See all 24 patients currently taking Tobramycin

Mouse over the table for more information

Reported Side Effects

Side effects as an overall problem

Severe
 0
Moderate
 0
Mild
 1
None
 1

Commonly reported side effects, conditions, and hospitalizations associated with Tobramycin

Increased secretions 1
Hospitalization 1

Reported Dosages

Frequently reported dosages based on patients currently taking Tobramycin. See all 16 dosages ►

  120 mg monthly 5 mL daily 10 mL daily 10 mg daily 20 mg daily 40 mg daily 60 mg daily 80 mg daily 120 mg daily 180 mg daily
  2 Number of Patients: 2 2 Number of Patients: 2 1 Number of Patients: 1 1 Number of Patients: 1 2 Number of Patients: 2 1 Number of Patients: 1 4 Number of Patients: 4 1 Number of Patients: 1 4 Number of Patients: 4 1 Number of Patients: 1  

Reported Stop Reasons

Why Patients Stopped Taking Tobramycin (multiple reasons could be selected)
Reason # Patients Percentage of patients
Course of treatment ended 3   Course of treatment ended: 60%
Side effects too severe 1   Side effects too severe: 20%
Not indicated 1   Not indicated: 20%

See all 5 patients who’ve stopped taking Tobramycin

Reported Duration See details about how long patients take this treatment ▼

Currently Taking Tobramycin

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0

Stopped Taking Tobramycin

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0

Reported Adherence, Burden & Cost See details from patient evaluations ▼

Adherence

Taking treatment as prescribed

Adherence of Tobramycin

Always
 0 0%
Usually
 1 50%
Sometimes
 1 50%
Never
 0 0%

Burden

Difficulty being on treatment

Burden of Tobramycin

Very
 1 50%
Somewhat
 1 50%
A little
 0 0%
Not at all
 0 0%

Cost

Paid out of pocket

Cost of Tobramycin

$200+
 0 0%
$100-199
 0 0%
$50-99
 0 0%
$25-49
 0 0%
< $25
 1 100%

See more information, including instructions, precautions, side effects, and interactions.

Report created on May 26, 2012.